Bundschuh RA - Search Results

1

Early biochemical and radiographic response after one cycle of [¹⁷⁷Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients.

Cytawa W, Hendel R, Tomasik B, Weinzierl FX, Bley T, Jassem J, Schirbel A, Buck AK, Bundschuh RA, Hartrampf PE, Werner RA, Lapa C. Cytawa W, et al. Among authors: bundschuh ra. Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3765-3776. doi: 10.1007/s00259-023-06326-w. Epub 2023 Jul 21. Eur J Nucl Med Mol Imaging. 2023. PMID: 37474735 Free PMC article.

2

Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours?

Al-Ibraheem A, Bundschuh RA, Notni J, Buck A, Winter A, Wester HJ, Schwaiger M, Scheidhauer K. Al-Ibraheem A, et al. Among authors: bundschuh ra. Eur J Nucl Med Mol Imaging. 2011 Nov;38(11):2005-13. doi: 10.1007/s00259-011-1875-0. Epub 2011 Jul 27. Eur J Nucl Med Mol Imaging. 2011. PMID: 21792572

3

Decision making for osteoporotic treatment using FRAX or DVO risk algorithms in a clinical setting.

Rendl S, Lapa C, Blümel C, Bundschuh RA, Schneider P. Rendl S, et al. Among authors: bundschuh ra. J Musculoskelet Neuronal Interact. 2013 Sep;13(3):339-45. J Musculoskelet Neuronal Interact. 2013. PMID: 23989255 Free article.

4

Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapy.

Lapa C, Werner RA, Schmid JS, Papp L, Zsótér N, Biko J, Reiners C, Herrmann K, Buck AK, Bundschuh RA. Lapa C, et al. Among authors: bundschuh ra. Nucl Med Biol. 2015 Apr;42(4):349-54. doi: 10.1016/j.nucmedbio.2014.12.006. Epub 2014 Dec 20. Nucl Med Biol. 2015. PMID: 25595135

5

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy.

Lapa C, Werner RA, Bluemel C, Lueckerath K, Muegge DO, Strate A, Haenscheid H, Schirbel A, Allen-Auerbach MS, Bundschuh RA, Buck AK, Herrmann K. Lapa C, et al. Among authors: bundschuh ra. EJNMMI Res. 2014 Dec 24;4:74. doi: 10.1186/s13550-014-0074-y. eCollection 2014. EJNMMI Res. 2014. PMID: 25977880 Free PMC article.

6

Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.

Werner RA, Kroiss M, Nakajo M, Mügge DO, Hahner S, Fassnacht M, Schirbel A, Bluemel C, Higuchi T, Papp L, Zsótér N, Buck AK, Bundschuh RA, Lapa C. Werner RA, et al. Among authors: bundschuh ra. Endocrine. 2016 Sep;53(3):791-800. doi: 10.1007/s12020-016-0970-1. Epub 2016 May 2. Endocrine. 2016. PMID: 27138903

7

Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity.

Werner RA, Lapa C, Ilhan H, Higuchi T, Buck AK, Lehner S, Bartenstein P, Bengel F, Schatka I, Muegge DO, Papp L, Zsótér N, Große-Ophoff T, Essler M, Bundschuh RA. Werner RA, et al. Among authors: bundschuh ra. Oncotarget. 2017 Jan 24;8(4):7039-7049. doi: 10.18632/oncotarget.12402. Oncotarget. 2017. PMID: 27705948 Free PMC article. Clinical Trial.

8

Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.

Lapa C, Reiter T, Kircher M, Schirbel A, Werner RA, Pelzer T, Pizarro C, Skowasch D, Thomas L, Schlesinger-Irsch U, Thomas D, Bundschuh RA, Bauer WR, Gärtner FC. Lapa C, et al. Among authors: bundschuh ra. Oncotarget. 2016 Nov 22;7(47):77807-77814. doi: 10.18632/oncotarget.12799. Oncotarget. 2016. PMID: 27780922 Free PMC article.

9

⁶⁸Ga-PSMA-PET/CT imaging of localized primary prostate cancer patients for intensity modulated radiation therapy treatment planning with integrated boost.

Thomas L, Kantz S, Hung A, Monaco D, Gaertner FC, Essler M, Strunk H, Laub W, Bundschuh RA. Thomas L, et al. Among authors: bundschuh ra. Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1170-1178. doi: 10.1007/s00259-018-3954-y. Epub 2018 Feb 21. Eur J Nucl Med Mol Imaging. 2018. PMID: 29468311

10

Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma.

Khawar A, Eppard E, Sinnes JP, Roesch F, Ahmadzadehfar H, Kürpig S, Meisenheimer M, Gaertner FC, Essler M, Bundschuh RA. Khawar A, et al. Among authors: bundschuh ra. Clin Nucl Med. 2018 Jul;43(7):486-491. doi: 10.1097/RLU.0000000000002102. Clin Nucl Med. 2018. PMID: 29688951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page